General
Preferred name
tubocurarine
Synonyms
TUBOCURARINE CHLORIDE PENTAHYDRATE ()
Tubocurarine ()
Jexin ()
Tubarine ()
TUBOCURARINE CHLORIDE ()
(+)-Tubocurarine chloride ()
NSC-757362 ()
Tubocurarini chloridum ()
Curare ()
Tubocurarine chloride, anhydrous ()
Cloruro de tubocurarina ()
Chlorure de tubocurarine ()
Tubarine pentahydrate ()
Tubocurarine chloride anhydrous ()
Tubocurarine chloride hydrochloride hydrate ()
Tubaine ()
Tubocurarine cation ()
d-Tubocurarine ()
Tubocurarine ion ()
P&D ID
PD009744
CAS
6989-98-6
57-94-3
57-95-4
1370-17-8
1390-11-0
8063-06-7
1406-69-5
41354-45-4
Tags
available
drug
natural product
Approved by
FDA
First approval
1945
Drug indication
Smoking dependence
Anaesthesia
Drug Status
approved
withdrawn
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Tubocurarine is a skeletal muscle relaxant. The structure as specified by the FDA and the INN document shows the compound in complex with chloride (see PubChem CID 9917490). As our data specifies the parent compound, it is this structure we have chosen to display here, and which the majority of entries linked to from the table above display. (GtoPdb)
DESCRIPTION Selective KV11.1 (hERG) channel activator (Tocris Bioactive Compound Library)
Cell lines
0
Organisms
1
Compound Sets
20
ChEMBL Approved Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
ReFrame library
The Spectrum Collection
Tocris Bioactive Compound Library
Withdrawn 2.0
External IDs
79
Properties
(calculated by RDKit )
Molecular Weight
609.3
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
8
Aromatic Ring Count
4
cLogP
6.7
TPSA
80.62
Fraction CSP3
0.35
Chiral centers
2.0
Largest ring
18.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
Nicotinic Receptors (Non-selective)
MOA
Antagonist
acetylcholine receptor antagonist
Target
ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN
Indication
anesthetic
ATC
M03AA02
Therapeutic Class
Neuromuscular Nondepolarizing Agents
Source data